Morgans says these ASX growth shares are buys

These growth stocks have caught the eyes of analysts over at Morgans.

| More on:
A young woman holding her phone smiles broadly and looks excited, after receiving good news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for some ASX growth shares to buy?

If you are then you might want to hear what Morgans is saying about the two listed below.

Here's why the broker thinks they could be in the buy zone:

Webjet Limited (ASX: WEB)

Morgans responded to this online travel booking company's half-year results by putting an add rating and $8.55 price target on its shares.

Based on the current Webjet share price of $6.66, this implies a potential upside of 28% for this ASX growth share over the next 12 months.

The broker was impressed with its performance during the half and believes there's a lot more to come. It commented:

Webjet reported a strong 1H24 result which beat expectations. The performance from WebBeds which posted a record result (bookings are 50% ahead of pre-COVID levels), its industry leading margins and strong operating cashflow were the highlights of the result.

Outlook commentary was upbeat, however the war has had an impact on bookings in the last six weeks. FY24 EBITDA guidance was in line with our forecast however if the impact from the war is short lived, it could prove conservative. With plenty of market share still to win, we maintain an Add rating on this high quality growth stock.

Treasury Wine Estates Ltd (ASX: TWE)

Another ASX growth share that has been given the thumbs up by Morgans is Treasury Wine.

Its analysts have an add rating and a $14.15 price target on the wine giant's shares. This suggests a potential upside of 33% for investors from current levels.

The broker is supportive of its recent acquisition in North America and has boosted its earnings estimates to reflect this. It said:

Treasury Wine Estates has announced the acquisition of Paso Robles luxury wine business, DAOU Vineyards (DAOU) for US$900m (A$1.4bn), funded by equity and debt. The acquisition is in line with TWE's premiumisation and growth strategy and will strengthen a key gap in Treasury Americas (TA) portfolio. Importantly, DAOU has generated solid earnings growth and is a high margin business.

TWE has consequently upgraded its margins targets. The acquisition is EPS accretive from FY25 and +US$20m of cost synergies are expected by FY26. We have upgraded our forecasts. On an FY25F PE of 17.5x, TWE is trading at a material discount to its 5-year average of ~25x and we maintain an Add rating. The key near term catalyst is China removing the tariffs on Australian wine imports.

Motley Fool contributor James Mickleboro has positions in Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »